Illustration of an industrial AirJoule-style system extracting clean water from humid air, symbolizing early-stage climate technology with high potential and high risk.

AirJoule Technologies (AIRJ): Water From Thin Air — and a Stock With Serious Upside?

AirJoule is building technology to extract pure water from air using waste heat — targeting data centers, industry, and defense. The vision is compelling, the partnerships are real, and the risks are just as real. This is a venture-style bet, not a safe harbor.

Read entire article

Illustration of a stylized crown hovering above biotech molecules and financial charts, representing XOMA Royalty’s strategy of collecting biotech royalties without developing drugs.

Can XOMA Become Royalty? The CEO, BVF Partners, and Morgan Stanley Think So!

XOMA Royalty doesn’t run clinical trials—it collects royalties. With a $2.5M CEO insider buy, heavyweight institutional backing, and improving cash flow, this biotech quiet achiever may be turning into something… royal.

Read entire article